Mycophenolate Mofetil Therapeutic Cheat Sheet
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m …
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m … Continue reading "Mycophenolate Mofetil Therapeutic Cheat Sheet"
On this Mnemonic Monday, we challenge you to remember major causes of drug-induced Stevens-Johnson Syndrome (SJS) with the following mnemonic:
SANA
Sulfonamides
Anticonvulsants
NSAIDs
Allopurinol
Click HERE to print your mnemonic card.
Study More!
Need a refresher on Stevens-Johnson Syndrome? Check out the following pages of your 2019 Derm In-Review Study Guide:
Stevens-Johnso … 
In this month’s installment of our Therapeutic Cheat Sheet Series, we will review the topical immunomodulatory agent imiquimod. Originally approved for the treatment of external genital warts, FDA approval has expanded to include use as field therapy for actinic keratoses as well as treatment of superficial basal cell carcinomas. Here’s what you need to know about imiquimod.
[caption id=" … 
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center.
COVID-19 DERM TOPICS
COVID-19 Peer-reviewed Articles
Safely Reopening Derm Practices Video Series
JDD COVID-19 Webinar Series
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi … 
CASE
A 47-year-old woman presented for Mohs Micrographic Surgery for a biopsy-proven basal cell carcinoma involving the right nasal ala. The patient had a history of basal cell nevus syndrome (BCNS) and previous history of multiple basal cell carcinomas.
On initial examination, the patient was noted to have a few scattered pearly molluscoid papules on the head and neck, which were suspicio … 